[Modified subcutaneous mastectomy. Apropos of 916 cases].
Modified subcutaneous mastectomy was described by one of us in 1968; its approach, the dissection of the gland, plastic reconstruction of shape and volume are completely different from the subcutaneous mastectomy performed by plastic surgeons. 3 different time periods were studied to explain clearly evolution in the technic and indications. During many years retrospective studies made it possible to build a procedure according to the new diagnostic means for infraclinical breast cancer and to the constant improving prosthetic material. Therefore our indications for modified subcutaneous mastectomy are as following: suspicious mastopathies are the best indications with a performing choice of the radiologic images which require histologic control some evolutive or evoluated mastopathies some small infiltrating tumors developing in a highly dystrophic glandular surrounding. The numerous in situ cancers accompanying them argue for this choice. some big phyllod tumors or phyllod's recurrences.
Reynier
J
J
Hôpital Boucicaut, Paris.
Arkwright
S
S
Chevalier
J M
JM
Lalo
J
J
Gonter
A
A
Goumot
P A
PA
Renody
N
N
Vilde
F
F
Villet
R
R
D018427:Breast Implants; D001943:Breast Neoplasms / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D015414:Mastectomy, Subcutaneous / Q000009:adverse effects / Q000379:methods / Q000639:trends*; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D016896:Treatment Outcome
Les mammectomies sous-cutanées modifiées. A propos de 916 observations.